This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

Amrize Ltd (AMRZ) Reports Q2 Earnings: What Key Metrics Have to Say

Amrize Ltd (AMRZ) reported $3.49 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 8.5%. EPS of $0.88 for the same period compares to $0.78 a year ago.

The reported revenue represents a surprise of +3.73% over the Zacks Consensus Estimate of $3.37 billion. With the consensus EPS estimate being $0.92, the EPS surprise was -4.35%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Amrize Ltd performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Revenues- Building Envelope: $1.05 billion compared to the $941.44 million average estimate based on three analysts.
Revenues- Building Materials: $2.45 billion versus $2.43 billion estimated by three analysts on average.
Adjusted EBITDA- Building Materials: $793 million versus the three-analyst average estimate of $833.15 million.
Adjusted EBITDA- Building Envelope: $237 million versus $226.8 million estimated by three analysts on average.
Adjusted EBITDA- Unallocated corporate costs: $-44 million versus $-50 million estimated by two analysts on average.

View all Key Company Metrics for Amrize Ltd here>>>

Shares of Amrize Ltd have returned +6.9% over the past month versus the Zacks S&P 500 composite's +3.3% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."

Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention.

See them now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Amrize Ltd (AMRZ): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research